| |
|
|
|
|
|
|
|||
|
CM Dubois, FW Ruscetti, SE Jacobsen, JJ Oppenheim and JR Keller
Laboratory of Immunoregulation, National Cancer Institute (NCI), Frederick,
MD.
Having previously shown that interleukin-1 (IL-1) induces the expression of
IL-1 receptors (IL-1Rs) on bone marrow (BM) cells in vivo through an
indirect mechanism, we studied whether hematopoietic growth factors (HGFs)
could induce the expression of IL-1R on BM cells in vitro. In vitro
treatment of light-density murine BM (LDBM) cells with either IL-3, IL-6,
granulocyte--colony-stimulating factor (CSF), or
granulocyte-macrophage--CSF caused a 5- to 10-fold upregulation of IL- 1R
expression, whereas IL-1, IL-5, IL-7, and macrophage-CSF had no effect.
Scatchard analysis showed one class of IL-1Rs on LDBM cells with an average
of 66 +/- 20 sites per cells. After 24 hours of treatment with IL-3, the
number of IL-1Rs increased to 413 +/- 125, without effecting the affinity.
This effect required protein synthesis, but was independent of cell
division. Purified lineage-negative progenitor cells (Lin-) did not express
detectable levels of IL-1R, but 24 hours of treatment with IL-3, GM-CSF,
and G-CSF stimulated IL-1-- specific binding. Autoradiographic analysis of
Lin- cells showed that IL-1R induction by IL-3 occurs on undifferentiated
blast cells. Affinity labeling of Lin- cells treated with HGFs showed an
increase in a 65-Kd IL-1 binding protein that did not bind or compete with
an anti- type I IL-1R antibody, suggesting that these cells expressed type
II IL- 1R. These data suggest that IL-1 stimulation of myelopoiesis occurs
by a mechanism involving IL-1R upregulation on hematopoietic progenitor
cells by HGFs.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1992 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||